23andMe Simvastatin Medication Insight Report

23andMe has released a new medication insight report for simvastatin as part of its 23andMe+ membership service. The pharmacogenetic report allows 23andMe+ subscribers to learn their likelihood of having side effects from the drug, which is sold under brand names including Flolipid and Zocor, based on a SLCO1B1 variant.